Cargando…
Discovery of 5-Phenoxy-2-aminopyridine Derivatives as Potent and Selective Irreversible Inhibitors of Bruton’s Tyrosine Kinase
As a member of the tyrosine protein kinase Tec (TEC) family, Bruton’s tyrosine kinase (BTK) is considered a promising therapeutic target due to its crucial roles in the B cell receptor (BCR) signaling pathway. Although many types of BTK inhibitors have been reported, there is an unmet need to achiev...
Autores principales: | Lee, Eun, Cho, Hyewon, Lee, Da Kyung, Ha, JuHyun, Choi, Byeong Jo, Jeong, Ji Hye, Ryu, Jae-Ha, Kang, Jong Soon, Jeon, Raok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663149/ https://www.ncbi.nlm.nih.gov/pubmed/33126415 http://dx.doi.org/10.3390/ijms21218006 |
Ejemplares similares
-
Discovery of Tricyclic Pyranochromenone as Novel Bruton’s Tyrosine Kinase Inhibitors with In Vivo Antirheumatic Activity
por: Cho, Hyewon, et al.
Publicado: (2020) -
Molecular Drug Discovery of Single Ginsenoside Compounds as a Potent Bruton’s Tyrosine Kinase Inhibitor
por: Lee, Keun Woo, et al.
Publicado: (2020) -
Discovery
of Potent and Selective Tricyclic Inhibitors of Bruton’s Tyrosine
Kinase with Improved Druglike Properties
por: Wang, Xiaojing, et al.
Publicado: (2017) -
Single cell imaging of Bruton's Tyrosine Kinase using an irreversible inhibitor
por: Turetsky, Anna, et al.
Publicado: (2014) -
ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer
por: Ghoshdastidar, Krishnarup, et al.
Publicado: (2020)